TickerFacts.

Akari Therapeutics Plc (AKTX): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2019-12-31
$54.8K2010-12-31: $02011-12-31: $02012-12-31: $02013-12-31: $02014-12-31: $02015-12-31: $10.6K2016-12-31: $54.8K2017-12-31: $36.9K2018-12-31: $02019-12-31: $0$0
2010-12-31 Capital Expenditures (USD) 2019-12-31
Period endedCapital ExpendituresChange YoYSource filing
2019-12-31$0n/a2020-03-31, From 2019-01-01
2018-12-31$0-100.0%2020-03-31, From 2018-01-01
2017-12-31$36.9K-32.6%2020-03-31, From 2017-01-01
2016-12-31$54.8K+418.5%2019-04-23, From 2016-01-01
2015-12-31$10.6Kn/a2018-07-18, From 2015-01-01
2014-12-31$0n/a2017-03-31, From 2014-01-01
2013-12-31$0n/a2015-02-11, From 2013-01-01
2012-12-31$0n/a2015-02-11, From 2012-01-01
2011-12-31$0n/a2014-03-24, From 2011-01-01
2010-12-31$0n/a2013-04-19, From 2010-01-01